AI assistant
Sending…
Alector, Inc. — Director's Dealing 2022
May 31, 2022
33290_dirs_2022-05-31_717c0540-ba78-454e-a6ac-7693640c262e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Alector, Inc. (ALEC)
CIK: 0001653087
Period of Report: 2022-05-27
Reporting Person: Romano Gary (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-27 | Common Stock | A | 92250 | $0.00 | Acquired | 92250 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-05-27 | Employee Stock Option (right to buy) | $9.20 | A | 369000 | Acquired | 2032-05-27 | Common Stock (369000) | Direct |
Footnotes
F1: The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on September 1, 2022.
F2: Shares subject to the option vest in 48 equal monthly installments beginning on June 23, 2022.
More from Alector, Inc.
Regulatory Filings
2026
May 7
Capital/Financing Update
2026
May 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 26
Annual Report
2026
Feb 25
Earnings Release
2026
Feb 25